Open Your FREE Demat Account Now!

N/A
indicator

Nifty Healthcare Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty Healthcare Index Performance

Low

₹15,344.25

High

₹15,665.30

52 Week Range

Low

₹13,536.50

High

₹16,941.70

Previous Close ₹15,557.60
Day's Range ₹15,344.25 - ₹15,665.30
Open ₹15,598.95
52 Week Range ₹13,536.50 - ₹16,941.70
Volume 2,03,49,330

Nifty Healthcare Index Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1314.00 Arrow -10.10 (-0.76%) Healthcare
Dr. Reddy's Laboratories Ltd. 1244.50 Arrow 2.00 (0.16%) Healthcare
Lupin Ltd. 1964.00 Arrow 24.80 (1.28%) Healthcare
Torrent Pharmaceuticals Ltd. 4553.80 Arrow -4.90 (-0.11%) Healthcare
Abbott India Ltd. 25680.00 Arrow -225.00 (-0.87%) Healthcare
Apollo Hospitals Enterprise Ltd. 7600.00 Arrow -100.00 (-1.30%) Healthcare
Ipca Laboratories Ltd. 1918.90 Arrow 104.40 (5.75%) Healthcare
Sun Pharmaceutical Industries Ltd. 1745.10 Arrow 2.10 (0.12%) Healthcare
Aurobindo Pharma Ltd. 1578.80 Arrow -42.60 (-2.63%) Healthcare
Glenmark Pharmaceuticals Ltd. 2194.10 Arrow -16.10 (-0.73%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 22811.35 26373.20 22179.90
Nifty IT 32422.5 40301.40 25699.10
Nifty Next 50 67655.3 75000.40 59896.10
NIFTY50 USD Index 8367.65 10443.40 7839.85
Nifty Bank 54976.9 61764.85 49954.85
NIFTY Midcap 100 57565.85 64450.90 52032.85
Nifty 500 21837.9 24144.20 20385.65
Nifty Midcap 50 16500.2 18500.95 14804.55
Nifty 100 23762.45 26975.15 22720.45
Nifty FMCG 43720.7 57445.20 43442.30

Latest News

Oct
21
2026
EQUITY Posted on Oct 21st 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has informed that it enclosed a copy of press release dated October 21, 2026, titled ‘Zydus receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
21
2026
EQUITY Posted on Oct 21st 2026

Dr. Reddy’s Laboratories informs about press release

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Receives DCGI Approval for Zytorvi® (toripalimab) in Advanced Esophageal Squamous Cell Carcinoma, Its Second Approved Indication in India’.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
19
2026
EQUITY Posted on Oct 19th 2026

Krishna Institute of Medical Sciences submits analyst meet intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed about the details of the proposed schedule of the Analyst/ Institutional Investor Meeting on November 16, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
19
2026
EQUITY Posted on Oct 19th 2026

Zydus Lifesciences submits board meeting intimation

Pursuant to the provisions of regulation 29(1) of the Listing Regulations, Zydus Lifesciences has informed that the meeting of the Board of Directors of Zydus Lifesciences will be held on Wednesday, November 4, 2026, to consider, apart from other agenda items, approval of unaudited financial results for the quarter / half year ended on September 30, 2026. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till Friday, November 6, 2026, and shall open for trading on and from Monday, November 9, 2026, for all the Directors and Designated Persons of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
14
2026
EQUITY Posted on Oct 14th 2026

Biocon informs about company statement

Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Secures Earliest Licensed Launch Dates for Pebrilzo® (bPertuzumab) Following Global Patent Settlement with Genentech’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NIFTYHEALTH index?

The previous close of NIFTYHEALTH index is ₹15507.15 as of 2026-10-21.

The total volume of NIFTYHEALTH index is 20349330.00 as of 2026-10-21.

The percentage change in value of NIFTYHEALTH index is -0.32% as of 2026-10-21.

The absolute increase in NIFTYHEALTH index value since the previous trading day is ₹-50.45 as of 2026-10-21.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore